Full Press Release Details
Solid Biosciences Provide Update Long Term Outcomes Data.
SLDB
Solid Biosciences Provide Update Long Term Outcomes Data
Key Takeaway: Solid Biosciences Provide Update Long Term Outcomes Data
Price reaction · baseline $42 (2021-09-17 close) · 1 other SLDB headline(s) in the window, move may be shared
day 0 close
-5%
day 1 · peak
+14.3%
day 3
+5.7%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+116%
120-day peak, hindsight
Typical move
7.4%
average across 7 past catalysts
Cash runway
~21 mo
Low dilution risk
Lead asset
carmustine
Phase 3 · Lymphoma